AARSD1 Inhibitors
AARSD1 inhibitors like Cycloheximide and Emetine are known to interfere with protein synthesis, which would reduce the production of AARSD1 along with other proteins. Compounds like Halofuginone and Rapamycin target specific enzymatic activities or signaling pathways, such as aminoacyl-tRNA synthetase activity and the mTOR pathway, respectively. The inhibition of these pathways can decrease the functional availability of AARSD1 within the cell. Other compounds like Tunicamycin, Brefeldin A, and Thapsigargin affect the post-translational modification, trafficking, and stability of proteins. Tunicamycin's interference with glycosylation, Brefeldin A's disruption of protein transport, and Thapsigargin's perturbation of calcium homeostasis can lead to a less conducive environment for AARSD1's stability or trafficking, indirectly diminishing its functional presence.
Moreover, metabolic inhibitors like 2-Deoxyglucose can disturb the energy balance within the cell, potentially affecting the energy-dependent processes of protein synthesis, wherein AARSD1 is included. Chloroquine and MG132 can influence the degradation of proteins; Chloroquine by altering autophagic processes and MG132 by inhibiting the proteasome, which can result in an accumulation of dysfunctional AARSD1.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis by interfering with the translocation step in protein elongation, which can indirectly reduce the functional pool of AARSD1 by preventing its synthesis. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1775.00 | ||
Inhibits prolyl-tRNA synthetase and can potentially influence the aminoacylation process in which AARSD1 is involved. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Causes premature chain termination during protein synthesis, which can non-specifically reduce the levels of AARSD1 along with other proteins. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR and may indirectly decrease the synthesis of AARSD1 by reducing overall protein translation. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, which can disrupt proper folding and stability of glycoproteins, potentially affecting AARSD1 if it undergoes glycosylation. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport by inhibiting the exchange of guanine nucleotide on ARF proteins, possibly affecting AARSD1 localization and function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Disrupts calcium homeostasis by blocking the calcium pump of the sarcoplasmic and endoplasmic reticulum, potentially affecting AARSD1 function if it is calcium-dependent. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Mimics glucose and interferes with glycolysis, which can reduce cellular energy levels and indirectly affect protein synthesis, including that of AARSD1. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Raises endosomal pH and can disrupt membrane trafficking and autophagy, potentially affecting AARSD1 degradation pathways. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Inhibits proteasome, which could lead to reduced degradation of misfolded or damaged AARSD1 proteins, indirectly affecting their function. | ||||||